(Q73046888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Regression to the truth: replication of association in pharmacogenetic studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Stephen G Ryan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

201-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Clinical epidemiological quality in molecular genetic research: the need for methodological standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Haplotype variation and linkage disequilibrium in 313 human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Genetic dissection of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Use of unlinked genetic markers to detect population stratification in association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Population genetic structure of variable drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Association mapping in structured populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Publication bias in editorial decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

The replication requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

An exact test for Hardy-Weinberg and multiple alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Serotonin transporter genetic variation and the response of the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.2.201.22631

10.1517/PHGS.4.2.201.22631

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12605554%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference